The Patent Finder

Hanall Pharmaceutical Co., Ltd.

Also on record
Records under this name other than patents Hanall Pharmaceutical Co., Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Hanall Pharmaceutical Co., Ltd.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 8,722,6741,3,5-Triazine-2,4,6-Triamine Compound or Pharmaceutical Acceptable Salt Thereof, and Pharmaceutical Composition Comprising the Same
Formerly held
Lapsed on the fee record
Ended May 13, 2026 · High confidence
Lapsed on the fee recordEnded May 13, 2026High confidence
US 8,642,083Controlled release complex composition comprising angiotensin-II-receptor blockers and HMG-CoA reductase inhibitors
Formerly held
Lapsed on the fee record
Ended Feb 4, 2026 · USPTO record
Lapsed on the fee recordEnded Feb 4, 2026USPTO record
US 8,541,474N,N-dimethyl imidodicarbonimidic diamide acetate, method for producing the same and pharmaceutical compositions comprising the same
Formerly held
Lapsed on the fee record
Ended Sep 24, 2025 · USPTO record
Lapsed on the fee recordEnded Sep 24, 2025USPTO record
US 7,611,700Protease resistant modified interferon alpha polypeptides
Formerly held
Term ended
Term ended Jan 19, 2025 · USPTO record
Term endedTerm ended Jan 19, 2025USPTO record
US 8,252,743Modified erythropoietin polypeptides and uses thereof for treatment
Formerly held
Lapsed on the fee record
Ended Aug 28, 2024 · USPTO record
Lapsed on the fee recordEnded Aug 28, 2024USPTO record
US 8,222,209Modified growth hormones that exhibit increased protease resistance and pharmaceutical compositions thereof
Formerly held
Lapsed on the fee record
Ended Jul 17, 2024 · USPTO record
Lapsed on the fee recordEnded Jul 17, 2024USPTO record
US 8,076,377N,N-dimethyl imidodicarbonimidic diamide dicarboxylate, method for producing the same and pharmaceutical compositions comprising the same
Lapsed on the fee record
Ended Dec 13, 2023 · USPTO record
Lapsed on the fee recordEnded Dec 13, 2023USPTO record
US 8,058,312N, N-dimethyl imidodicarbonimidic diamide acetate, method for producing the same and pharmaceutical compositions comprising the same
Formerly held
Lapsed on the fee record
Ended Nov 15, 2023 · USPTO record
Lapsed on the fee recordEnded Nov 15, 2023USPTO record
US 8,114,839Protease resistant modified erythropoietin polypeptides
Formerly held
Term ended
Term ended Sep 8, 2023 · USPTO record
Term endedTerm ended Sep 8, 2023USPTO record
US 7,998,469Protease resistant interferon beta mutants
Formerly held
Lapsed on the fee record
Ended Aug 16, 2023 · USPTO record
Lapsed on the fee recordEnded Aug 16, 2023USPTO record
10 of 17 patents shown.
Pro members see all 17.
Pro members: see all 17 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited